These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15109023)

  • 1. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs.
    Hu J; Johnston KP; Williams RO
    Drug Dev Ind Pharm; 2004 Mar; 30(3):233-45. PubMed ID: 15109023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supercritical fluid particle design for poorly water-soluble drugs (review).
    Sun Y
    Curr Pharm Des; 2014; 20(3):349-68. PubMed ID: 23651403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs.
    Rogers TL; Gillespie IB; Hitt JE; Fransen KL; Crowl CA; Tucker CJ; Kupperblatt GB; Becker JN; Wilson DL; Todd C; Broomall CF; Evans JC; Elder EJ
    Pharm Res; 2004 Nov; 21(11):2048-57. PubMed ID: 15587927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
    Tran CTM; Tran PHL; Tran TTD
    Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology.
    Hu J; Rogers TL; Brown J; Young T; Johnston KP; Williams RO
    Pharm Res; 2002 Sep; 19(9):1278-84. PubMed ID: 12403063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology versus other techniques in improving drug dissolution.
    Kwok PC; Chan HK
    Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of acidic poorly water soluble drugs into ionic liquids.
    Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
    Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems.
    Hu J; Johnston KP; Williams RO
    Eur J Pharm Sci; 2003 Nov; 20(3):295-303. PubMed ID: 14592695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
    Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
    Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid dispersions, part II: new strategies in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1663-80. PubMed ID: 21919806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of particle size on the dissolution behaviors of poorly water-soluble drugs.
    Chu KR; Lee E; Jeong SH; Park ES
    Arch Pharm Res; 2012 Jul; 35(7):1187-95. PubMed ID: 22864741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
    Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.
    Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO
    Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.